A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint
暂无分享,去创建一个
[1] S J Pocock,et al. The combination of randomized and historical controls in clinical trials. , 1976, Journal of chronic diseases.
[2] M Nurminen,et al. Comparative analysis of two rates. , 1985, Statistics in medicine.
[3] J. Ibrahim,et al. Power prior distributions for regression models , 2000 .
[4] Donald J. Schuirmann. A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability , 1987, Journal of Pharmacokinetics and Biopharmaceutics.
[5] J. Heyse,et al. Statistical Considerations for NonInferiority/Equivalence Trials in Vaccine Development , 2006, Journal of biopharmaceutical statistics.
[6] Hiroshi Nishiyama,et al. Introduction of "Points to Consider on Switching between Superiority and Non-inferiority" and "Guideline on the Choice of the Non-inferiority Margin" , 2006 .
[7] Penny M Heaton,et al. Concomitant Use of an Oral Live Pentavalent Human-Bovine Reassortant Rotavirus Vaccine With Licensed Parenteral Pediatric Vaccines in the United States , 2007, The Pediatric infectious disease journal.
[8] Draft Guidance. Guidance for Industry Non-Inferiority Clinical Trials , 2010 .
[9] Muhtarjan Osman,et al. Semiparametric Bayesian Testing Procedure for Noninferiority Trials with Binary Endpoints , 2011, Journal of biopharmaceutical statistics.
[10] Bradley P Carlin,et al. Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials , 2011, Biometrics.
[11] Ram C Tiwari,et al. Bayesian Approach to Noninferiority Trials for Proportions , 2011, Journal of biopharmaceutical statistics.
[12] Joseph G Ibrahim,et al. Bayesian Design of Noninferiority Trials for Medical Devices Using Historical Data , 2011, Biometrics.
[13] Bradley P Carlin,et al. Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models. , 2012, Bayesian analysis.
[14] Fang Chen,et al. Use of historical control data for assessing treatment effects in clinical trials , 2014, Pharmaceutical statistics.
[15] Ram C Tiwari,et al. Bayesian approach to the design and analysis of non‐inferiority trials for anti‐infective products , 2014, Pharmaceutical statistics.
[16] Anthony O'Hagan,et al. Robust meta‐analytic‐predictive priors in clinical trials with historical control information , 2014, Biometrics.
[17] T. Ng. Noninferiority Testing in Clinical Trials : Issues and Challenges , 2014 .
[18] G. Liu,et al. Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in Infants , 2015, Pediatrics.
[19] Brian L. Wiens,et al. Design and Analysis of Non-Inferiority Trials , 2020 .